Requirement of a novel splicing variant of human histone deacetylase 6 for TGF-β1-mediated gene activation

Biochemical and Biophysical Research Communications

Volumn 392, Issue 4, 2010, Pages 608-613

  Zhuang, Yan ^a   Nguyen, Hong T ^a   Lasky, Joseph A ^a   Cao, Subing ^a   Li, Cui ^a,b   Hu, Jiyao ^a   Guo, Xinyue ^a   Burow, Matthew E ^a   Shan, Bin ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Epithelial mesenchymal transition; Histone deacetylase 6; Transforming growth factor 1

Indexed keywords

ALPHA TUBULIN; COMPLEMENTARY DNA; HISTONE DEACETYLASE 6; MESSENGER RNA; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN MCF 7; CELL TRANSFORMATION; DEACETYLATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MESENCHYME CELL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; CELL LINE, TUMOR; GENE EXPRESSION; HISTONE DEACETYLASES; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTIONAL ACTIVATION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 76749107384     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.01.091     Document Type: Article

References (15)

1. Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T., Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.J., and Zhao Y. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 23 (2006) 607-618
2. Boyault C., Sadoul K., Pabion M., and Khochbin S. HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination. Oncogene 26 (2007) 5468-5476
3. Bertos N.R., Gilquin B., Chan G.K., Yen T.J., Khochbin S., and Yang X.J. Role of the tetradecapeptide repeat domain of human histone deacetylase 6 in cytoplasmic retention. J. Biol. Chem. 279 (2004) 48246-48254
4. Pandey U.B., Batlevi Y., Baehrecke E.H., and Taylor J.P. HDAC6 at the intersection of autophagy, the ubiquitin-proteasome system and neurodegeneration. Autophagy 3 (2007) 643-645
5. Boyault C., Zhang Y., Fritah S., Caron C., Gilquin B., Kwon S.H., Garrido C., Yao T.P., Vourc'h C., Matthias P., and Khochbin S. HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates. Genes Dev. 21 (2007) 2172-2181
6. Hubbert C., Guardiola A., Shao R., Kawaguchi Y., Ito A., Nixon A., Yoshida M., Wang X.F., and Yao T.P. HDAC6 is a microtubule-associated deacetylase. Nature 417 (2002) 455-458
7. Kovacs J.J., Murphy P.J., Gaillard S., Zhao X., Wu J.T., Nicchitta C.V., Yoshida M., Toft D.O., Pratt W.B., and Yao T.P. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol. Cell 18 (2005) 601-607
8. Kawaguchi Y., Kovacs J.J., McLaurin A., Vance J.M., Ito A., and Yao T.P. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115 (2003) 727-738
9. Westendorf J.J., Zaidi S.K., Cascino J.E., Kahler R., van Wijnen A.J., Lian J.B., Yoshida M., Stein G.S., and Li X. Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter. Mol. Cell. Biol. 22 (2002) 7982-7992
10. Girdwood D., Bumpass D., Vaughan O.A., Thain A., Anderson L.A., Snowden A.W., Garcia-Wilson E., Perkins N.D., and Hay R.T. P300 transcriptional repression is mediated by SUMO modification. Mol. Cell 11 (2003) 1043-1054
11. Shan B., Yao T.P., Nguyen H.T., Zhuo Y., Levy D.R., Klingsberg R.C., Tao H., Palmer M.L., Holder K.N., and Lasky J.A. Requirement of HDAC6 for transforming growth factor-beta1-induced epithelial-mesenchymal transition. J. Biol. Chem. 283 (2008) 21065-21073
12. Pugacheva E.N., Jablonski S.A., Hartman T.R., Henske E.P., and Golemis E.A. HEF1-dependent Aurora A activation induces disassembly of the primary cilium. Cell 129 (2007) 1351-1363
13. Weldon C.B., Parker A.P., Patten D., Elliott S., Tang Y., Frigo D.E., Dugan C.M., Coakley E.L., Butler N.N., Clayton J.L., Alam J., Curiel T.J., Beckman B.S., Jaffe B.M., and Burow M.E. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. Int. J. Oncol. 24 (2004) 1473-1480
14. Shan B., Zhuo Y., Chin D., Morris C.A., Morris G.F., and Lasky J.A. Cyclin-dependent kinase 9 is required for tumor necrosis factor-alpha-stimulated matrix metalloproteinase-9 expression in human lung adenocarcinoma cells. J. Biol. Chem. 280 (2005) 1103-1111
15. Haggarty S.J., Koeller K.M., Wong J.C., Grozinger C.M., and Schreiber S.L. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc. Natl. Acad. Sci. USA 100 (2003) 4389-4394